A detailed history of May Hill Capital, LLC transactions in Haemonetics Corp stock. As of the latest transaction made, May Hill Capital, LLC holds 22,348 shares of HAE stock, worth $1.64 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
22,348
Previous 17,917 24.73%
Holding current value
$1.64 Million
Previous $1.34 Billion 18.52%
% of portfolio
0.32%
Previous 0.44%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025

BUY
$47.67 - $78.17 $211,225 - $346,371
4,431 Added 24.73%
22,348 $1.09 Billion
Q2 2025

Aug 01, 2025

SELL
$56.04 - $74.77 $1,288 - $1,719
-23 Reduced 0.13%
17,917 $1.34 Billion
Q1 2025

Apr 30, 2025

BUY
$59.34 - $80.05 $1,483 - $2,001
25 Added 0.14%
17,940 $1.14 Billion
Q4 2024

Feb 12, 2025

BUY
$71.16 - $93.38 $1.27 Million - $1.67 Million
17,915 New
17,915 $1.4 Billion

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.77B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track May Hill Capital, LLC Portfolio

Follow May Hill Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of May Hill Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on May Hill Capital, LLC with notifications on news.